Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Drug composition for treating puberty polycystic ovarian syndrome

A polycystic ovary and syndrome technology, applied in the field of medicine, can solve the problems that surgery is not suitable for young women, hormone therapy cannot completely solve the problem of patients, and excessive androgen

Inactive Publication Date: 2016-04-13
段希福
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Its pathogenesis is not fully understood, but it is generally believed that androgen excess is the basis
Androgen can stimulate the growth of small follicles, but too much androgen hinders the maturation of follicles and affects the negative feedback of the hypothalamus, resulting in increased LH secretion and a relative decrease in FSH secretion, and the increased LH stimulates the production of ovarian theca cells. The reduction of FSH hinders the development of follicles, which causes irregular ovulation or anovulation, and finally causes a vicious cycle-continuous thinning of menstruation and clinical and biochemical hyperandrogen manifestations
[0004] At present, there is no cure for PCOS in Western medicine. Hormone therapy cannot completely solve the problem of patients, and it is prone to adverse reactions when used in large quantities for a long time; surgery is even more unsuitable for teenage women.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Drug composition for treating puberty polycystic ovarian syndrome
  • Drug composition for treating puberty polycystic ovarian syndrome
  • Drug composition for treating puberty polycystic ovarian syndrome

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0069] Embodiment 1 capsule

[0070] Prescription: 18 servings of Liuyuexue, 20 servings of Qianzhen Wanxiancao, 10 servings of Piper longum root, 10 servings of Soil Arrow, 20 servings of Milk Chai, 9 servings of Cyperus Cyperus, 15 servings of Cuscuta, 12 servings of Luer Ling, Lao Lai 15 parts of green, 12 parts of japonica root.

[0071] Preparation method: take Piper longum root, Cyperus cyperi, Luerling, Laolaiqing, Yangquehua root and 50% ethanol solution with 4-8 times the amount of medicinal materials, extract twice, each time for 1.5-2.0 hours, while hot Filtrate and concentrate until alcohol-free to obtain a concentrated ethanol extract; take Liuyuexue, Qianzhen Wanxiancao, Tujianqi, Milkchai, Cuscuta and Piper longum root, Cyperus cyperi, Luerling, Laolaiqing, Yang After the ethanol extraction of the sparrow root, filter the residue, add 4-10 times the water to soak for 3-4 hours, decoct and extract twice, each time for 1.5-2.0 hours (start timing from boiling); fil...

Embodiment 2

[0073] Embodiment 2 capsules

[0074] Prescription: 15 servings of Liuyuexue, 20 servings of Qianzhen Wanxiancao, 12 servings of Longan longan root, 12 servings of Astragalus, 15 servings of milk chai, 10 servings of Cyperus cyperus, 18 servings of dodder seed, 10 servings of deer ear feathers, 12 parts of green, 15 parts of japonica root.

[0075] Preparation method: with reference to Example 1.

Embodiment 3

[0076] Embodiment 3 capsules

[0077] Prescription: 18 servings of Liuyuexue, 22 servings of Qianzhen Wanxiancao, 12 servings of Longan longan root, 8 servings of Tujianqi, 17 servings of milk chai, 8 servings of Cyperus cyperi, 18 servings of dodder seed, 15 servings of deer ear feathers, 15 parts of green, 12 parts of japonica root.

[0078] Preparation method: with reference to Example 1.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the technical field of drugs and relates to a drug composition for treating a puberty polycystic ovarian syndrome and a preparation method of the drug composition. The drug composition is prepared from medicinal raw materials of herbs of snow of June, stellaria yunnanensis, roots of long pepper, roots of longflower stringbush, roots or leaves of ficus pandurata hance, nutgrass galingale rhizomes, seeds of Chinese dodder, winged laggera herbs, daylily and roots of franchet peashrub in accordance with a certain weight part ratio. The medicinal raw materials are used compatibly and can strengthen spleen and soothe liver, and for the puberty polycystic ovarian syndrome and particularly the symptoms of spleen deficiency and liver stagnation, the drug composition treats both symptoms and root causes and is good in effect.

Description

technical field [0001] The invention belongs to the technical field of medicine, and relates to a pharmaceutical composition for treating adolescent polycystic ovary syndrome and a preparation method thereof. Background technique [0002] Adolescent polycystic ovary syndrome (adolescentpolycysticovarysyndronie, PCOS) is a disease caused by endocrine disorders in adolescent girls. It increases the incidence of obesity, dyslipidemia, type 2 diabetes, hypertension and cardiovascular disease, dysfunctional uterine bleeding, and endometrial cancer in adolescent women. The clinical causes and pathological mechanisms of PCOS in adolescence are various, and the clinical manifestations are not the same, and because the physiological changes caused by the instability of the hypothalamus-pituitary-ovary axis in female puberty are similar, misdiagnosis and missed diagnosis are very easy to occur, which in turn affects adolescent females. patient's quality of life. Therefore, it is ext...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/8905A61P15/00
CPCA61K36/28A61K36/185A61K36/282A61K36/36A61K36/39A61K36/41A61K36/47A61K36/48A61K36/60A61K36/67A61K36/74A61K36/83A61K36/8905A61K2236/331A61K2236/333A61K2236/39A61K2236/51A61K2236/53A61K2300/00
Inventor 段希福
Owner 段希福
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products